Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty
Running, not enrolling · Not applicable
Conditions studied: Osteoarthritis of the Hip, Degenerative Joint Disease of Hip, Dysplasia; Hip
In brief
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Key facts
- Study ID
- NCT06792539
- Run by
- JointMedica Inc.
- People needed
- 238
- Starts
- 2025-01-22
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2026-05-01
Who can join
Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Florida Medical Clinic Orlando Health — Tampa, Florida, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Sinai Hospital / LifeBridge Health — Baltimore, Maryland, United States
- NYU Longone — New York, New York, United States
- Joint Implant Surgeons — New Albany, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Midlands Orthopaedics & Neurosurgery — Columbia, South Carolina, United States
- Hampton Road Orthopaedics — Newport News, Virginia, United States
- Orthopaedic and Physiotherapy Associates — Paget, Trevelyan, Bermuda
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.